- Home
- AMBC vs CGEM Comparison
AMBC vs CGEM Comparison
Compare AMBC & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- CGEM
- Stock Information
- Founded
- AMBC 1991
- CGEM 2016
- Country
- AMBC United States
- CGEM United States
- Employees
- AMBC N/A
- CGEM N/A
- Industry
- AMBC Property-Casualty Insurers
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- CGEM Health Care
- Exchange
- AMBC Nasdaq
- CGEM Nasdaq
- Market Cap
- AMBC 635.7M
- CGEM 730.2M
- IPO Year
- AMBC 1991
- CGEM 2021
- Fundamental
- Price
- AMBC $11.86
- CGEM $11.56
- Analyst Decision
- AMBC Strong Buy
- CGEM Strong Buy
- Analyst Count
- AMBC 2
- CGEM 7
- Target Price
- AMBC $17.00
- CGEM $31.67
- AVG Volume (30 Days)
- AMBC 666.5K
- CGEM 492.1K
- Earning Date
- AMBC 02-25-2025
- CGEM 11-07-2024
- Dividend Yield
- AMBC N/A
- CGEM N/A
- EPS Growth
- AMBC N/A
- CGEM N/A
- EPS
- AMBC N/A
- CGEM N/A
- Revenue
- AMBC $398,000,000.00
- CGEM N/A
- Revenue This Year
- AMBC N/A
- CGEM N/A
- Revenue Next Year
- AMBC N/A
- CGEM N/A
- P/E Ratio
- AMBC N/A
- CGEM N/A
- Revenue Growth
- AMBC 22.46
- CGEM N/A
- 52 Week Low
- AMBC $11.82
- CGEM $10.00
- 52 Week High
- AMBC $11.93
- CGEM $30.19
- Technical
- Relative Strength Index (RSI)
- AMBC 39.14
- CGEM 41.13
- Support Level
- AMBC $12.17
- CGEM $11.75
- Resistance Level
- AMBC $12.84
- CGEM $12.99
- Average True Range (ATR)
- AMBC 0.46
- CGEM 0.82
- MACD
- AMBC -0.10
- CGEM 0.11
- Stochastic Oscillator
- AMBC 4.78
- CGEM 44.01
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.